Dementia 2 Flashcards

1
Q

AD Risk factors

A

increasing age, females, family history of dementia, low education, low income, low occupational status, depression, head injury, low folate/B12, high homocysteine, presence of apolipoprotein E4 allele, postop delirium, alcohol abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Early symptoms of AD

A

cognitive symptoms: trouble keeping appointments, difficulty finding words, misplacing objects
functional symptoms: diff driving, diff selecting clothes, missing appointments, problems at work
Behavioral symptoms: subtle changes in personality, social withdrawal, depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

patients with depression vs. dementia

A

patients with depression demonstrate less motivation during cognitive testing. express cognitive complaints that exceed measured deficits. maintain language and motor skills.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when do you image brain?

A

focal findings on exam. rapid onset/decline. falls/head trauma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

treatment for frontotemporal dementia

A

no role for cholinesterase inhibitors. careful use of atypical antipsychotics. divalproex for behavioral control. SSRIs for irritability, depression, impulsive behaviors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharmacotherapy for alzheimer’s disease

A

cholinergic therapy, NMDA receptor antagonists, investigational agents, treatment of neuropsychiatric symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why do anticholinesterases work?

A

degeneration of basal nucleus of Meynert results in acetylcholine deficiency. this contributes to memory deficits. anticholinesterases block degradation of acetylcholine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 acetylcholinesterase inhibitors

A

Tacrine (obsolete), donepezil (approved for all stages of AD), rivastigmine, galantamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

memantine

A

targets excitotoxicity, which may cause neuronal damage. glutamate NMDA receptor blocker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

first approach if someone has neuropsychiatric disturbances in AD

A

find the trigger for disturbances and avoid them. if that doesnt work, antipsychotics, antidepressants, anxiolytics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vascular dementia

A

multi-infarct dementia. cerebral amyloid angiopathy. hypertension related small vessel disease. stepwise progression. usually seen with cardiovasc risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hypertensive small vessel disease and progressive cognitive impairment

A

arteriosclerosis of small arteris supplying deep grey and white matter. lacunar infacts. subcortical leukoencephalopathy. Subcortical dementia: cognitive slowing, impaired problem solving, visuospatial abnormalities, disturbances of mood and affect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does hypertension particularly affect?

A

small vessels such as the lenticulostriate. these supply deep structures such as the basal ganglia and internal capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treating vascular dementia

A

focus on controlling cardio risk factors. max blood pressure control, statins, stop smoking, control blood sugar, mental and physical exercise, diet. treat with cholinesterase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

lewy body dementia

A

intracellular, fibriller deposits of a presynaptic terminal protein called alpha synuclein. sporadic disorders. parkinson’s and dementia with lewy bodies are most common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

parkinson’s disease

A

sporadic. resting tremor, difficulty initiating movement, slowed movement, rigidity, shuffling gait, postural instability. dopaminergic deficit. responsive to L-Dopa treatment. pallow of the substantia nigra. degeneration and loss of pigmented dopaminergic neurons of substantia nigra. often contain lewy bodies.

17
Q

pathogenesis of Parkinsons

A

mutations in alpha synuclein gene. lewy bodies are composed of fibriller aggregates of alpha synuclein. pesticide exposure may be risk factor. oxidative stress, impaired axonal transport, inhibition of oxidative phosphorylation implicated in pathogenesis

18
Q

dementia with lewy bodies

A

sporadic, late onset. memory less frequently effected compared to AD. frontal and subcortical features (attention deficit and alertness) common. pronounced fluctuations and variations in symptoms. vivid hallucinations, delusions. sleep disorders common. acting out dreams

19
Q

neuropathology of lewy body dementia

A

nigral pallor. significant atrophy of limbic areas. cortical type lewie bodies in frontal, temporal, and insular cortex, and in limbic areas. nigral lewy bodies. lewy neurites. Usually plaques and tangles.

20
Q

lewy body dementia treatment

A

cholinesterase inhibitors may provide symptomatic support. trial of carbidopa/levodopa for movement symptoms. AVOID antipsychotics, as they make parkinson symptoms a lot worse. clonazepam for sleep disorders

21
Q

what are first areas to show lewy bodies in LBD

A

amygdala and cingulate gyrus

22
Q

LBD vs Parkinson dementia

A

LBD: onset of dementia within 12 months of parkinsonism. movement disorder usually second.

parkinson dementia: onset of dementia more than 12 months after diagnosis of parkinsons. movement disorder usually first